The Clinical Use of Cisapride in Gastro-oesophageal Reflux Disease, with Particular Focus on the Long-term Treatment Aspects

References

• Damman H G. Treatment of gastroesophageal reflux disease with ranitidine. Advances in drag therapy of gastroesophageal reflux disease, C Scarpignato, Front Gastrointest Res 1992, 20, 208–30
   Google Scholar
• Bardhan K D. Omeprazole in the treatment of gastroesophageal reflux disease. Advances in drug therapy of gastroesophageal reflux disease, C Scarpignato, Front Gastrointest Res 1992, 20, 46–306
   Google Scholar
• Firoucci S, Santucci L, Perrone E, Abbritti F, Morelli A. Gastric and esophageal acidity during continuous treatment with H2-antagonists in uncomplicated esophagitis. Scand J Gastroenterol 1989; 24: 671
   PubMedGoogle Scholar
• Hurlimann S, Abbuhl B, Inauen W, Halter F. Comparison of acid inhibition by either oral high-dose ranitidine or omeprazole. Aliment Pharmacol Ther 1994; 8: 193–201
   PubMed Web of Science ®Google Scholar
• Merki H S, Halter F, Wilder-Smith C H. Diurnal secretory patterns and tolerance during individually titrated infusion of ranitidine. Gastroenterology 1993; 105: 748–54
   PubMedGoogle Scholar
• Armstrong D, Verdu E, Fraser R, Viani F, Idstrom J P, Cederberg C, et al. Helicobacter pylori infection augments the antisecretory effect of omeprazole. Acta Gastr Bel 1993, Suppl 129
   Google Scholar
• Bardhan K D. Is there any acid peptic disease that is refractory to proton pump inhibitors?. Aliment Pharmacol Ther 1993; 7(Suppl 1)13–24
   PubMed Web of Science ®Google Scholar
• Lamberts R, Creutzfeldt W, Strüber H G, Brunner G, Solcia E. Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth and gastritis. Gastroenterology 1993; 104: 1356–70
   PubMed Web of Science ®Google Scholar
• Singh P, Adamopoulos A, Taylor R H, Colin-Jones D G. Oesophageal motor function before and after healing of oesophagitis. Gut 1992; 33: 1590–6
   PubMed Web of Science ®Google Scholar
• Echardt V F. Does healing of esophagitis improve esophageal motor function?. Dig Dis Sci 1988; 33: 161–5
   PubMedGoogle Scholar
• Howard J M, Frei J V, Flowers M, Bondy D C, Tilbe K, Reynolds R PE. Omeprazole heals esophagitis but does not improve abnormal esophageal motility in reflux esophagitis. Gastroenterology 1990; 98: A61
   Google Scholar
• Sito E, Thor P J, Maczka M, Lorens K, Konturek S J, Maj A. Double-blind crossover study of ranitidine and ebrotidine in gastro-esophageal reflux disease. J Physiol Pharmacol 1993; 44: 259–72
   PubMedGoogle Scholar
• Taniyama K, Nakayama S, Takeda K, Matsuyama S, Shirakawa J, Sanu I, et al. Cisapride stimulates motility of the intestine via the 5-hydroxytryptamine receptors. J Pharmacol Exp Ther 1991; 258: 1098–104
   PubMed Web of Science ®Google Scholar
• Ceccatelli P, Janssens J, Vantrappen G, Cucchiara S. Cisapride restores the decreased lower oesophageal sphincter pressure in reflux patients. Gut 1988; 29: 631–5
   PubMedGoogle Scholar
• Corinaldesi R, Stanghellini V, De Giorgio R, Barbara L. Cisapride in gastroesophageal reflux disease: effect on gastric emptying and clinical results. Advances in drug therapy of gastroesophageal reflux disease, C Scarpignato, Front Gastrointest Res 1992, 20, 70–80
   Google Scholar
• Maddern G J, Jamieson G G, Myers J C, Collins P J. Effect of cisapride on delayed gastric emptying in gastro-oesophageal reflux disease. Gut 1991; 32: 470–4
   PubMed Web of Science ®Google Scholar
• Bright N, Whelan G, Russell C. Effect of cisapride on oesophageal propulsive force and manometric pressure waves. Gut 1989; 30: A728
   Google Scholar
• Eriksen C A, Sutton D, Kennedy N, Cuschieri A. Effect of cisapride on oesophageal transit: results of a prospectively randomised clinical trial. Gullet 1990; 1: 31–5
   Google Scholar
• Rezen de Filho J, Di Lorenzo C, Dooley C P, Valenzuela J E. Cisapride stimulates antral motility and decreases biliary reflux in patients with severe dyspepsia. Dig Dis Sci 1989; 34: 1057–62
   PubMedGoogle Scholar
• Baldi F, Porro Bianchi G, Dobrilla G, Iascone C, Lobello R, Marzio L, et al. Cisapride versus placebo in reflux esophagitis. A multicenter double-blind trial. J Clin Gastroenterol 1988; 10: 614–8
   PubMed Web of Science ®Google Scholar
• Lepoutre L, Van der Spek P, Vanderlinden I, Bollen J, Laukens P, et al. Healing of grade II and III oesophagitis through motility stimulation with cisapride. Digestion 1990; 45: 109–14
   PubMed Web of Science ®Google Scholar
• Dodds W, Champion M, Orr W, Robinson M, Spechler S, Gilmore P, et al. Oral cisapride in GERD: a double-blind placebo-controlled multicenter trial. Gastroenterology 1989; 96: A126
   Google Scholar
• Faruqui S, Sigmund C, Smith R, Fitch D, Mellow M, Orr W, et al. Cisapride in the treatment of GERD: a double-blind, placebo-controlled multicenter dose-response trial. Gastroenterology 1992; 102: A66
   Google Scholar
• DeMicco M, Berenson M, Wu W, Castell D, Lanza F, Robinson M, et al. Cisapride in the treatment of GERD. A double-blind placebo-controlled multicenter dose-response trial. Gastroenterology 1992; 102: A59
   Google Scholar
• Galmiche J P, Fraitag B, Filoche B, Evreux M, Vitaux J, Zeitoun P, et al. Double-blind comparison of cisapride and cimetidine in treatment of reflux esophagitis. Dig Dis Sci 1990; 35: 649–55
   PubMed Web of Science ®Google Scholar
• Maleev A, Mendizova A, Popov P, Vlahov V, Dimitrov B, Mihova A, et al. Cisapride and cimetidine in the treatment of erosive esophagitis. Hepato-gastroenterol 1990; 37: 403–7
   PubMedGoogle Scholar
• Janisch H D, Hüttemann W, Bouzo M H. Cisapride versus ranitidine in the treatment of reflux esophagitis. Hepato-gastroenterol 1988; 35: 125–7
   PubMedGoogle Scholar
• Geldof H, Hazelhoff B, Otten M H. Two different dose regimens of cisapride in the treatment of reflux oesophagitis: a double-blind comparison with ranitidine. Aliment Pharmacol Ther 1993; 7: 409–15
   PubMed Web of Science ®Google Scholar
• Wienbeck M, the Ranpride Study Group. Does a motor stimulating agent improve the therapeutic effect of H2-blockers in reflux esophagitis?. Digestion 1986; 34: A144
   Google Scholar
• Galmiche J P, Brandstatter G, Evreux M, Hentschel E, Kerstan E, Kratochvil P, et al. Combined therapy with cisapride and cimetidine in severe reflux oesophagitis: a double-blind controlled trial. Gut 1988; 29: 675–81
   PubMed Web of Science ®Google Scholar
• Wienbeck M, the Ranpride Study Group, II. Does motor stimulation by cisapride added to acid inhibition by H2-receptor blockade improve healing rates in patients with reflux oesophagitis?. Int Symp on Pharmacotherapy of Gastrointestinal Motor Disorders, AdelaideSouth Australia, September, 2–41990
   Google Scholar
• Inauen W, Emde C, Weber B, Armstrong D, Bettschen H U, Huber T, et al. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24-hour ambulatory combined pH and manometry study. Gut 1993; 34: 1025–31
   PubMedGoogle Scholar
• Ollyo J-B, Monnier P, Fontolliet C, Savary M. The natural history, prevalence and incidence of reflux oesophagitis. Gullet 1993; 3: 3–10
   Google Scholar
• Tytgat G NJ, Hansen Anker OJ, Carling L, de Groot G H, Geldof H, Glise H, et al. Effect of cisapride on relapse of reflux oesophagitis, healed with an antisecretory drug. Scand J Gastroenterol 1992; 27: 175–83
   PubMed Web of Science ®Google Scholar
• Koelz H R, Birchler R, Bretholz A, Bron B, Capitaine Y, Delmore G, et al. Healing and relapse of reflux esophagitis during treatment with ranitidine. Gastroenterology 1986; 91: 1198–205
   PubMed Web of Science ®Google Scholar
• Hetzel D J, Dent J, Reed W D, Nariel Vala F M, McKinnon M, McCarthy J H, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988; 95: 903–12
   PubMed Web of Science ®Google Scholar
• Sandmark S, Carlsson R, Fausa O, Lundell L. Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study. Scand J Gastroenterol 1988; 23: 625–32
   PubMed Web of Science ®Google Scholar
• Silveira J CB, Barbosa J, Barreiros J, Beija B, Ferreira L SA, Freitas J, et al. Cisapride versus ranitidine in the treatment and prevention of recurrent oesophagitis. Hellenic J Gastroenterol 1992; 5: 324, Suppl
   Google Scholar
• Barbara L, Baldi F, Longanesi A, Ferrarini F, Michieletti G. Long-term maintenance of healed esophagitis. Advances in drug therapy of gastroesophageal reflux disease, C Scarpignato, Front Gastrointest Res 1992, 20, 357–65
   Google Scholar
• Laursen L S, Bondesen S, Hansen J, Sanches G, Sebelin E, Havrelund T, et al. Omeprazole 10 mg or 20 mg daily for the prevention of relapse in gastroesophageal reflux disease? A double-blind comparative study. Gastroenterology 1992; 102: A109
   PubMedGoogle Scholar
• Toussaint J, Gossuin A, Deruyttere M, Hublè F, Devis G. Healing and prevention of reflux oesophagitis by cisapride. Gut 1991; 32: 1280–5
   PubMed Web of Science ®Google Scholar
• Blum A L, Adami B, Bouzo M H, Branstätter G, Fumagalli I, Galmiche J P, et al. Effect of cisapride on relapse of esophagitis. A multinational, placebo-controlled trial in patients healed with an antisecretory drug. Dig Dis Sci 1993; 38: 551–60
   PubMed Web of Science ®Google Scholar
• Sherbaniuk R, Wensel R, Bailey R, et al. Ranitidine in the treatment of symptomatic gastrooesophageal reflux disease. J Clin Gastroenterol 1984; 6: 9–15
   PubMed Web of Science ®Google Scholar
• Sontag S, Vlahcevic R, Orr W C, et al. Ranitidine versus placebo in long-term treatment of gastroesophageal reflux (GERD). Gastroenterology 1986; 91: 1198–205
   PubMedGoogle Scholar
• Vigneri S, Termini R, Leandro G, Pantalena M, Savarino V, Badalamenti S, et al. Comparison between five long-term treatment options for reflux esophagitis: a multicenter study. The 4th OESO meeting, ParisFrance, September, 1–41993
   Google Scholar
• Lieberman D A. Medical therapy for chronic reflux esophagitis. Arch Intern Med 1987; 147: 1717–21
   PubMedGoogle Scholar
• Dallemagne B. Endoscopic approaches to oesophageal disease. Baillieres Clin Gastroenterol 1993; 7(4)795–822
   PubMedGoogle Scholar